Multispectral imaging and pathology: Seeing and doing more

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 9, 2008, Pages 1067-1081

  Levenson, Richard M ^a   Fornari, Alessandro ^b,c   Loda, Massimo ^b,d  

^a Cambridge Research & Instrumentation Inc   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TURIN   (Italy)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Image analysis; Immunofluorescence; Immunohistochemistry; Machine vision; Multispectral imaging; Oncology; Pathology; Personalized medicine; Segmentation

Indexed keywords

CONTRAST MEDIUM; EPIDERMAL GROWTH FACTOR RECEPTOR 2 ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUORESCENT DYE; QUANTUM DOT; UNCLASSIFIED DRUG;

AUTOFLUORESCENCE; BLOOD DISEASE; CANCER CELL; CHRONIC LYMPHATIC LEUKEMIA; DIAGNOSTIC IMAGING; DIGITAL IMAGING; FLUORESCENCE MICROSCOPY; HUMAN; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LABELING INDEX; MICROSCOPE; MICROSCOPE IMAGE; MOLECULAR IMAGING; NONHUMAN; OPTICS; PATHOLOGIST; PATHOLOGY; PROSTATE CANCER; QUANTITATIVE ANALYSIS; REVIEW; SCANNING ELECTRON MICROSCOPY; SCORING SYSTEM; SPECTROSCOPY; T CELL LYMPHOMA;

EID: 77953388970     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.9.1067     Document Type: Review

References (114)

1. Gal AA. In search of the origins of modern surgical pathology. Adv Anat Pathol 2001;8(1):1-13
2. Wells WA, Barker PE, MacAulay C, et al. Validation of novel optical imaging technologies: the pathologists' view. J Biomed Opt 2007;12(5):051801 (Pubitemid 351309599)
3. Patel K, Nelson DR, Rockey DC, et al. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C. Clin Gastroenterol Hepatol 2008;6(2):242-247
4. Farris AB, Misdraji J, Srivastava A, et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008;32(1):30-35
5. Novara G, Martignoni G, Artibani W, Ficarra V. Grading systems in renal cell carcinoma. J Urol 2007;177(2):430-436 (Pubitemid 46054036)
6. Martinez AE, Lin L, Dunphy CH. Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry. Arch Pathol Lab Med 2007;131(7):1084-1088 (Pubitemid 47057897)
7. Kerkhof M, Van Dekken H, Steyerberg EW, et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathol 2007;50(7):920-927 (Pubitemid 46850080)
8. Gerhard R, Da Cunha, Santos G. Inter- and intraobserver reproducibility of thyroid fine needle aspiration cytology: an analysis of discrepant cases. Cytopathology 2007;18(2):105-111 (Pubitemid 46496712)
9. Raab SS, Meier FA, Zarbo RJ, et al. The 'Big Dog' effect: variability assessing the causes of error in diagnoses of patients with lung cancer. J Clin Oncol 2006;24(18):2808-2814 (Pubitemid 46630580)
10. Quinn M. Newfoundland launches judicial inquiry. CMAJ 2007;177(1):24-25
11. Goldstein NS, Hunter S, Forbes S, et al. Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity. Appl Immunohistochem Mol Morphol 2007;15(2):203-207 (Pubitemid 46828230)
12. Morales AR, Nassiri M, Kanhoush R, et al. Experience with an automated microwave-assisted rapid tissue processing method: validation of histologic quality and impact on the timeliness of diagnostic surgical pathology. Am J Clin Pathol 2004;121(4):528-536 (Pubitemid 38392960)
13. Leong AS, Price D. Incorporation of microwave tissue processing into a routine pathology laboratory: impact on turnaround times and laboratory work patterns. Pathology 2004;36(4):321-324 (Pubitemid 39178971)
14. Chu WS, Liang Q, Tang Y, et al. Ultrasound-accelerated tissue fixation/processing achieves superior morphology and macromolecule integrity with storage stability. J Histochem Cytochem 2006;54(5):503-13 • This indicates the promise of combining conventional formalin fixation with high-intensity ultrasound. The resulting local agitation and cavitation may help to physically drive the fixative through the tissue, improving molecular preservation while preserving excellent morphology.
15. Oyama T, Ishikawa Y, Hayashi M, et al. The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer. Breast Cancer 2007;14(2):182-188
16. Bankfalvi A, Boecker W, Reiner A. Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests. Int J Oncol 2004;25(4):929-935
17. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847 (Pubitemid 28331029)
18. Aperio homepage. Available from: http//www.aperio.com [Accessed 12 Aug 2008 ]
19. Hamamatsu: Virtual Microscopy/NanoZoomer. Available from: http://sales.hamamatsu.com/en/products/system-division/virtual-microscopy.php [Accessed 12 Aug 2008]
20. 3DHISTECH homepage. Available from: http://www.3dhistech.com/ [Accessed 12 Aug 2008 ]
21. BioImagene homepage. Available from: http://www.bioimagene.com/ [Accessed 12 Aug 2008]
22. Cualing HD, Zhong E, Moscinski L 'Virtual flow cytometry' of immunostained lymphocytes on microscopic tissue slides: iHCFlow tissue cytometry. Cytometry B Clin Cytom 2007;72(1):63-76
23. Carl Zeiss homepage. Available from: http://www.zeiss.com/ [Accessed 12 Aug 2008]
24. TissueGnostics homepage. Available from: http://www.tissuegnostics.com// index.php?load = xml/en/home.xml&lang=en [Accessed 12 Aug 2008]
25. Titford M. The long history of hematoxylin. Biotech Histochem 2005;80(2):73-78 (Pubitemid 41403363)
26. Heller RE. A requiem for aniline dyes. Perspect Biol Med 1992;35(3):398-400
27. Coleman R. The long-term contribution of dyes and stains to histology and histopathology. Acta Histochem 2006;108(2):81-83 (Pubitemid 43866194)
28. Taylor CR, Cote RJ. Immunohistochemical markers of prognostic value in surgical pathology. Histol Histopathol 1997;12(4):1039-1055 (Pubitemid 27410462)
29. Nelson PT, Baldwin DA, Kloosterman WP, et al. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 2006;12(2):187-91 • An early demonstration of in situ miRNA imaging in formalin-fixed tissue using chromogenic detection. (Pubitemid 43121922)
30. Nelson PT, De Planell-Saguer M, Lamprinaki S, et al. A novel monoclonal antibody against human Argonaute proteins reveals unexpected characteristics of miRNAs in human blood cells. RNA 2007;13(10):1787-1792 (Pubitemid 47481686)
31. Jeffrey SS. Cancer biomarker profiling with microRNAs. Nat Biotechnol 2008;26(4):400-401
32. Takahashi M, Rhodes DR, Furge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001;98(17):9754-9759 (Pubitemid 32769376)
33. Simone NL, Bonner RF, Gillespie JW, et al. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 1998;14(7):272-276 (Pubitemid 28341788)
34. Fend F, Emmert-Buck MR, Chuaqui R, et al. Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol 1999;154(1):61-66 (Pubitemid 29031612)
35. Lubieniecka JM, Nielsen TO. cDNA microarray-based translational research in soft tissue sarcoma. J Surg Oncol 2005;92(4):267-271 (Pubitemid 41779280)
36. Banks RE, Dunn MJ, Forbes MA, et al. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis - preliminary findings. Electrophoresis 1999;20(4-5):689-700 (Pubitemid 29222417)
37. Frable WJ. Pathologic classification of soft tissue sarcomas. Semin Surg Oncol 1994;10(5):332-339 (Pubitemid 24300050)
38. Bacus SS, Altomare Da, Lyass L, et al. AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene 2002;21(22):3532-3540 (Pubitemid 34587685)
39. Reddy RK, Mao C, Baumeister P, et al. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003;278(23):20915-20924 (Pubitemid 36806399)
40. Cicenas J, Urban P, Vuaroqueaux V, et al. Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. Breast Cancer Res 2005;7(4):R394-401
41. David O, Jett J, Lebeau H, et al. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res 2004;10(20):6865-6871 (Pubitemid 39383035)
42. Tokunaga E, Kimura Y, Oki E, et al. Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. Int J Cancer 2006;118(2):284-289 (Pubitemid 41779066)
43. Lugli A, Zlobec I, Minoo P, et al. Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer - a tissue microarray-based approach. Hum Pathol 2006;37(8):1022-1031 (Pubitemid 44080807)
44. Vestey SB, Sen C, Calder CJ, et al. Activated Akt expression in breast cancer: correlation with p53, Hdm2 and patient outcome. Eur J Cancer 2005;41(7):1017-1025 (Pubitemid 40602853)
45. Yamamoto S, Tomita Y, Hoshida Y, et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 2004;10(8):2846-2850 (Pubitemid 38509164)
46. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 2003;4(4):257-262 (Pubitemid 37329790)
47. Bergqvist J, Elmberger G, Ohd J, et al. Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen. Eur J Cancer 2006;42(8):1104-1112
48. Digiovanna MP, Stern DF. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. Cancer Res 1995;55(9):1946-1955
49. Akobundu E, Ju J, Blatt L, Mullins CD. Cost-of-Illness studies: a review of current methods. Pharmacoeconomics 2006;24(9):869-890 (Pubitemid 44338298)
50. Van Den Akker-Van Marle ME, Gurwitz D, Detmar SB, et al. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe. Pharmacogenomics 2006;7(5):783-792 (Pubitemid 44225913)
51. Schacker T, Reilly C, Beilman G, et al. Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count. AIDS 2005;19(18):2169-2171 (Pubitemid 41669008)
52. Ring BZ, Seitz RS, Beck R, et al. Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(19):3039-3047 (Pubitemid 46638938)
53. Loussouarn D, Brunon J, Avet-Loiseau H, et al. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fl uorescence in situ hybridization study. Hum Pathol 2006;37(4):415-421
54. Wiseman SM, Makretsov N, Nielsen TO, et al. Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival. Cancer 2005;103(9):1770-1777
55. Jayaram G, Elsayed EM. Cytologic evaluation of prognostic markers in breast carcinoma. Acta Cytol 2005;49(6):605-610 (Pubitemid 41667077)
56. Makretsov NA, Huntsman DG, Nielsen TO, et al. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma. Clin Cancer Res 2004;10(18):6143-51 • A competing analytical tool to expression micro-arrays, with the benefit that the cellular localization information is preserved when immunohistochemical techniques are used.
57. Abdul-Rasool S, Kidson SH, Panieri E, et al. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J Clin Pathol 2006;59(3):289-297 (Pubitemid 43344892)
58. Rubin MA, Zerkowski MP, Camp RL, et al. Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements. Am J Pathol 2004;164(3):831-840 (Pubitemid 38235465)
59. Fountaine TJ, Wincovitch SM, Geho DH, et al. Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots. Mod Pathol 2006;19(9):1181-1191 (Pubitemid 44268188)
60. Mansfield JR, Gossage KW, Hoyt CC, Levenson RM. Autofl uorescence removal, multiplexing, and automated analysis methods for in vivo fl uorescence imaging. J Biomed Opt 2005;10(4):41207 (Pubitemid 43328899)
61. Levenson RM, Mansfield JR. Multispectral imaging in biology and medicine: slices of life. Cytometry A 2006;69(8):748-758 (Pubitemid 44469987)
62. Clancy B, Cauller LJ. Reduction of background autofl uorescence in brain sections following immersion in sodium borohydride. J Neurosci Methods 1998;83(2):97-102 (Pubitemid 28442600)
63. Baschong W, Suetterlin R, Laeng RH. Control of autofl uorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM). J Histochem Cytochem 2001;49(12):1565-1572 (Pubitemid 34093111)
64. Staughton TJ, Mcgillicuddy CJ, Weinberg PD. Techniques for reducing the interfering effects of autofl uorescence in fl uorescence microscopy: improved detection of sulphorhodamine B-labelled albumin in arterial tissue. J Microsc 2001;201(Pt 1):70-76 (Pubitemid 32151137)
65. Neumann M, Gabel D. Simple method for reduction of autofl uorescence in fl uorescence microscopy. J Histochem Cytochem 2002;50(3):437-439 (Pubitemid 34171067)
66. Taylor CR, Levenson RM. Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment II. Histopathology 2006;49(4):411-424 (Pubitemid 44401549)
67. Zhou R, Hammond EH, Parker DL. A multiple wavelength algorithm in color image analysis and its applications in stain decomposition in microscopy images. Med Phys 1997;23(12):1977-1986
68. Levenson RM. Spectral imaging perspective on cytomics. Cytometry A 2006;69(7):592-600 (Pubitemid 44060593)
69. Van der Loos CM: Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. J Histochem Cytochem 2008;56(4):313-328
70. Speel EJ, Jansen MP, Ramaekers FC, Hopman AH. A novel triple-color detection procedure for brightfield microscopy, combining in situ hybridization with immunocytochemistry. J Histochem Cytochem 1994;42(10):1299-1307 (Pubitemid 24307719)
71. Macville MV, Van Der Laak JA, Speel EJ, et al. Spectral imaging of multi-color chromogenic dyes in pathological specimens. Anal Cell Pathol 2001;22(3):133-142 (Pubitemid 32673747)
72. Szeszel MK, Crisman CL, Crow L, et al. Quantifying estrogen and progesterone receptor expression in breast cancer by digital imaging. J Histochem Cytochem 2005;53(6):753-762 (Pubitemid 40726955)
73. Farkas DL, Du C, Fisher GW, et al. Non-invasive image acquisition and advanced processing in optical bioimaging. Comput Med Imaging Graph 1998;22(2):89-102 (Pubitemid 28400198)
74. Garini Y, Young IT, McNamara G. Spectral imaging: principles and applications. Cytometry A 2006;69(8):735-47 • A review article from some of the pioneers of spectral imaging and microscopy.
75. Bearman G, Levenson R. Biological imaging spectroscopy. In: Vo-Dinh T, editor, Biomedical photonics handbook. Boca Raton: CRC Press; 2003
76. Barber PR, Vojnovic B, Atkin G, et al. Applications of cost-effective spectral imaging microscopy in cancer research. J Phys D Appl Phys 2003;36:1729-1738
77. Ghazani AA, Lee JA, Klostranec J, et al. High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett 2006;6(12):2881-2886 (Pubitemid 46129588)
78. Levenson R. Putting the 'more' back in morphology: spectral imaging and image analysis in the service of pathology. Arch Pathol Lab Med 2008;132:748-757
79. Matkowskyj KA, Cox R, Jensen RT, Benya RV. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J Histochem Cytochem 2003;51(2):205-214 (Pubitemid 36160047)
80. Ermert L, Hocke AC, Duncker HR, et al. Comparison of different detection methods in quantitative microdensitometry. Am J Pathol 2001;158(2):407-417 (Pubitemid 32158604)
81. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. WHO; 2001
82. Cheson BD. The myelodysplastic syndromes: current approaches to therapy. Ann Intern Med 1990;112(12):932-941 (Pubitemid 20193679)
83. Hamblin T. Immunologic abnormalities in myelodysplastic syndromes. Hematol Oncol Clin North Am 1992;6(3):571-586
84. Sebban C, Browman GP, Lepage E, Fiere D. Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemotherapy trials. Leuk Res 1995;19(11):861-868 (Pubitemid 26009456)
85. Schultz KR, Massing B, Spinelli JJ, et al. Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukaemia. Med Pediatr Oncol 1997;29(1):16-22 (Pubitemid 27194734)
86. Sievers EL. Antibody-targeted chemotherapy of acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg). Blood Cells Mol Dis 2003;31(1):7-10 (Pubitemid 36802237)
87. Lambertenghi-Deliliers G, Annaloro C, Oriani A, et al. Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Ann Hematol 1993;66(2):85-91 (Pubitemid 23079674)
88. Oertel J, Oertel B, Schleicher J, Huhn D. Immunotyping of blasts in human bone marrow. Ann Hematol 1996;72(3):125-129 (Pubitemid 26107622)
89. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 2005;13(3):205-220 (Pubitemid 41209013)
90. Dunleavy K, Wilson WH, Jaffe ES. Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol 2007;14(4):348-353 (Pubitemid 46842809)
91. Dupuis J, Boye K, Martin N, et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL):a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006;30(4):490-494 (Pubitemid 43740150)
92. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988;12(6):433-443 (Pubitemid 18155106)
93. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med 2006;12(3):296-300 (Pubitemid 43355075)
94. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Ann Rev Med 2007;58:267-284 (Pubitemid 46706514)
95. Shipitsin M, Polyak K. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest 2008;88(5):459-463 (Pubitemid 351581449)
96. Adamson JW, Fialkow PJ, Murphy S, et al. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med 1976;295(17):913-916
97. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3(7):730-737 (Pubitemid 27298715)
98. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100(7):3983-3988 (Pubitemid 36418143)
99. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65(13):5506-5511 (Pubitemid 40911148)
100. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006;6(6):425-436
101. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65(23):10946-10951 (Pubitemid 41713363)
102. Hart LS, El-Deiry WS. Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J Clin Oncol 2008;26(17):2901- 2910
103. Balic M, Lin H, Young L, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006;12(19):5615-5621 (Pubitemid 44629587)
104. Schieker M, Pautke C, Haasters F, et al. Human mesenchymal stem cells at the single-cell level: simultaneous seven-colour immunofl uorescence. J Anat 2007;210(5):592-599 (Pubitemid 46647827)
105. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002;8(11):1323-1327 (Pubitemid 35373567)
106. Haralick RM. Statistical and structural approaches to texture. Proc IEEE 1979;67:786-804 (Pubitemid 9446710)
107. Mansoor I, Zalles C, Zahid F, et al. Fine-needle aspiration of follicular adenoma versus parathyroid adenoma: the utility of multispectral imaging in differentiating lesions with subtle cytomorphologic differences. Cancer 2008;114(1):22-26 (Pubitemid 351304609)
108. Bachmann IM, Straume O, Puntervoll HE, et al. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005;11(24 Pt 1):8606-8614 (Pubitemid 43005907)
109. Dolled-Filhart M, Mccabe A, Giltnane J, et al. Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 2006;66(10):5487-5494 (Pubitemid 43844977)
110. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452:580-589
111. Lee H, Douglas-Jones AG, Morgan JM, Jasani B. The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma. J Clin Pathol 2002;55(3):236-238 (Pubitemid 34250915)
112. Sharifi AM, Roach C, Wakamiya K, Askaa J. Deterioration of phospho-epitopes prior to and during specimen fixation [abstract 748]. Proc Am Assoc Cancer Res 2005;46 • An important alert to the critical effects that sample handing variability can have on the qualitative and quantitative measurements of labile, significant proteins and their modifications.
113. Weinstein RS. The S-curve framework: predicting the future of anatomic pathology. Arch Pathol Lab Med 2008;132:739-742 (Pubitemid 351632845)
114. Friedman BA. A survey of the myriad forces changing anatomic pathology and their consequences. Arch Pathol Lab Med 132:735-738 (Pubitemid 351632844)